Conjugate vaccines

Clinical and Experimental Immunology

Volumn 119, Issue 1, 2000, Pages 1-3

  Goldblatt, D ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN SUBCLASS; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; VACCINE;

ANTIBODY RESPONSE; CONJUGATION; DRUG EFFICACY; EDITORIAL; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; INFANT; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; MOLECULAR DYNAMICS; PRIORITY JOURNAL; SEROTYPING; STREPTOCOCCUS INFECTION; VACCINATION;

BACTERIAL VACCINES; CHILD; GLYCOCONJUGATES; HAEMOPHILUS VACCINES; HUMANS; IMMUNOLOGIC MEMORY; INFANT; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 0033985486     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01109.x     Document Type: Editorial

References (34)

1. 1 Peltola H, Kilpi T, Anttila M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet 1992; 340:592-4.
2. 2 Santosham M, Wolff M, Reid R et al. The efficacy in Navajo infants of conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med 1991; 324:1767-72.
3. 3 Booy R, Hodgson S, Carpenter L et al. Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T. Lancet 1994; 344:362-6.
4. 4 Peltola H, Käyhty H, Sivonen A, Mäkelä PH. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics 1977; 60:730-7.
5. 5 Makela PH, Sibakov M, Herva E et al. Pneumococcal vaccine and otitis media. Lancet 1980; ii:547-51.
6. 6 Baker PJ. T cell regulation of the antibody response to bacterial polysaccharide antigens: an examination of some general characteristics and their implications. J Infect Dis 1992; 165 (Suppl. 1): S44-S48.
7. 7 Gold R, Lepow M, Goldschneider I, Draper L, Gotschlich EC. Clinical evaluation of Group A and Group C meningococcal polysaccharide vaccines in infants. J Clin Invest 1975; 56:1536-47.
8. 8 Käyhty H, Karanko V, Peltola H, Mäkelä PH. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory. Pediatrics 1984; 74:857-65.
9. 9 O'Brien KL, Steinhoff MC, Edwards K, Keyserling H, Thoms ML, Madore D. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines. Pediatr Infect Dis J 1996; 15:425-30.
10. 10 Konradsen HB. Quantity and avidity of pneumococcal antibodies before and up to five years after pneumococcal vaccination of elderly persons. Clin Infect Dis 1995; 21:616-20.
11. 11 Avery OT, Goebel WF. Chemo-immunological studies on conjugated carbohydrate-proteins. II. Immunological specificity of synthetic sugar-proteins. J Exp Med 1929; 50:521-33.
12. 12 Ward J, Berkowitz C, Pescetti J. Enhanced immunogenicity in young infants of a new Haemophilus influenzae type b capsular polysaccharide (PRP)-diphtheria toxoid (D) conjugate vaccine. Pediatr Res 1984; 18:287A
13. 13 Granoff DM, Anderson EL, Osterholm MT et al. Differences in the immunogenicity of three Haemophilus influenzae type b vaccines in infants. J Pediatr 1992; 121:187-94.
14. 14 Schlesinger Y, Granoff DM. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group. JAMA 1992; 267:1489-94.
15. 15 Granoff DM, Shackelford PG, Holmes SJ, Lucas AH. Variable region expression in the antibody responses of infants vaccinated with Haemophilus influenzae type b polysaccharide-protein conjugates. Description of a new lambda light chain-associated idiotype and the relation between idiotype expression, avidity, and vaccine formulation. The Collaborative Vaccine Study Group. J Clin Invest 1993; 91:788-96.
16. 16 Steinhoff MC, Edwards K, Keyserling H et al. A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines in young children: effect of polysaccharide size and linkage characteristics. Pediatr Infect Dis J 1994; 13:368-72.
17. 17 Kayhty H, Ahman H, Ronnberg PR, Tillikainen R, Eskola J. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J Infect Dis 1995; 172:1273-8.
18. 18 Twumasi PA Jr, Kumah S, Leach A et al. A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. J Infect Dis 1995; 171:632-8.
19. 19 Anttila M, Eskola J, Ahman H, Kayhty H. Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood. Vaccine 1999; 17:1970-7.
20. 20 Granoff DM, Weinberg GA, Shackelford PG. IgG subclass response to immunization with Haemophilus influenzae type b polysaccharide -outer membrane protein conjugate vaccine. Pediatr Res 1988; 24:180-5.
21. 21 Ambrosino DM, Sood S, Lee MC et al. IgG1, IgG2 and IgM responses to two Haemophilus influenzae type b conjugate vaccines in infants. Pediatr Infect Dis J 1992; 11:855-9.
22. 22 Vella PP, Marburg S, Staub JM et al. Immunogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F and a meningococcal outer membrane protein complex. Infect Immun 1992; 60:4977-83.
23. 23 Soininen A, Seppala I, Nieminen T, Eskola J, Kayhty H. IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines. Vaccine 1999; 17:1889-97.
24. 24 Kayhty H, Eskola J, Peltola H, Saarinen L, Makela PH. High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines. J Infect Dis 1992; 165:S165-S166.
25. 25 Leach A, Twumasi PA Jr, Kumah S et al. Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J Infect Dis 1997; 175:200-4.
26. 26 Goldblatt D, Pinto Vas R, Miller E. Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccine following infant immunization. J Infect Dis 1998; 177:1112-5.
27. 27 Richmond PC, Goldblatt D, Fusco PC, Fusco JDS, Heron I, Clark S, Borrow R, Michon F. Safety and immunogenicity of a new Neisseria meningitidis Group C-tetanus toxoid conjugate vaccine in healthy adults. Vaccine 1999; in press.
28. 28 Goldblatt D, Richmond P, Millard E, Thornton C, Miller E. The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination. J Infect Dis 1999; 180:538-41.
29. 29 Coughlin RT, White AC, Anderson CA, Carlone GM, Klein DL, Treanor J. Characterization of pneumococcal specific antibodies in healthy unvaccinated adults. Vaccine 1998; 16:1761-7.
30. 30 Johnson SE, Rubin L, Romero-Steiner S et al. Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae. J Infect Dis 1999; 180:133-40.
31. 31 Black S, Shinefield HR, Ray P et al. Efficacy of a heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37000 infants and children: results of the Northern California Kaiser Permanante Trial. Pneumococcal vaccines for the world. Washington: 1998.
32. 32 Dagan R, Muallem M, Melamed R, Leroy O, Yagupsky P. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr Infect Dis J 1997; 16:1060-4.
33. 33 Obaro SK, Adegbola RA, Banya WAS, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination. Lancet 1996; 348: 271-2.
34. 34 Mbelle N, Wasas A, Huebner R, Kimura A, Chang I, Klugman K. Immunogenicity and impact on carriage of 9-valent pneumococcal conjugate vaccine given to infants in Soweto, South Africa. ICAAC LB21, 1997.